Continued pricing pressures from governments and patient groups are driving small molecule CDMOs to focus on reducing the ...

ARCALYST® (rilonacept) 2024 net product revenue of $416.4 million (unaudited), representing ~79% year-over-year growth –– ...

Shares of Neimeth International Pharmaceuticals Plc have risen by over 32% in the third week of January 2025, pushing its ...

Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability ...

Through its engagement with OTC pharmaceutical suppliers, logistics companies, and merchants on Chinese e-commerce platforms, Joint Cross Border provides a convenient one-stop solution for Mainland ...

We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to ...

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) just unveiled an update. Botanix Pharmaceuticals Limited has announced a change in the interest of ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Brexpiprazole Tablets.

Through its engagement with OTC pharmaceutical suppliers, logistics companies, and merchants on Chinese e-commerce platforms, Joint Cross Border provides a convenient one-stop solution for Mainland ...

Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $15.2, a high estimate of ...

Zlata Pharma LLP launched its new wellness product range with the aim of establishing itself as a key player in India's healthcare sector. The event highlighted their mission to position Goa ...